MOORE LUCK TRINIDAD: Open Payments
NPI 1891492773 · EUGENE, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$653 in 29 payments from 11 companies in 2025. Trend: 2023 $54 · 2024 $815 · 2025 $653
Food & beverage: $653
| Company | Payments | Amount |
|---|---|---|
| Exact Sciences Corporation | 11 | $192 |
| ABBVIE INC. | 3 | $144 |
| Novo Nordisk Inc | 4 | $69 |
| Otsuka America Pharmaceutical, Inc. | 3 | $51 |
| GlaxoSmithKline, LLC. | 2 | $50 |
| Lilly USA, LLC | 1 | $30 |
| Kowa Pharmaceuticals America, Inc. | 1 | $30 |
| Organon LLC | 1 | $24 |
| Genentech USA, Inc. | 1 | $24 |
| Aimmune Therapeutics, Inc. | 1 | $22 |
Products named: VRAYLAR, The Cologuard Plus Collection Kit, Cologuard Collection Kit, REXULTI, TRELEGY ELLIPTA, Wegovy, MOUNJARO, ZORYVE.
Industry payments across OR — which companies pay providers there.
